New from me: DNA sequencing company Element Biosciences, a David to Illumina's Goliath, has raised a $277 million investment round with an aim to accelerate commercialization of its Aviti sequencers, now installed in nearly 200 labs. www.forbes.com/sites/alexkn...

With $277 Million In New Funding, This Startup Hopes To Unlock The Secrets Of Biology

Element Biosciences has figured out how to decrypt a cell’s genetic code. And it’s using artificial intelligence to build better tools for doctors and researchers.